Niagen Bioscience Inc (NAGE) valuation
Niagen Bioscience P/E ratio history
Niagen Bioscience trades at 12.9 times its earnings over the last twelve months.
| Fiscal year ended | Price | EPS | P/E |
|---|---|---|---|
| Dec 31, 2025 | $6.36 | $0.20 | 31.8 |
| Dec 31, 2024 | $5.30 | $0.11 | 48.2 |
| Dec 31, 2023 | $1.43 | -$0.07 | n/m |
| Dec 31, 2022 | $1.68 | -$0.24 | n/m |
| Dec 31, 2021 | $3.74 | -$0.40 | n/m |
| Dec 31, 2020 | $4.80 | -$0.33 | n/m |
| Dec 31, 2019 | $4.31 | -$0.56 | n/m |
| Dec 31, 2018 | $3.43 | -$0.61 | n/m |
| Dec 30, 2017 | $5.88 | -$0.25 | n/m |
| Dec 31, 2016 | $3.31 | -$0.08 | n/m |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Niagen Bioscience valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Niagen BioscienceNAGE | $186M | 12.9 | — | 1.4 |
| B And G FoodsBGS | $188M | — | 4.3 | 0.1 |
| LimoneiraLMNR | $194M | — | 61.4 | 1.5 |
| Natures Sunshine ProductsNATR | $215M | 12.1 | 10.6 | 0.4 |
| Nu Skin EnterprisesNUS | $226M | — | 4.7 | 0.2 |
| MedifastMED | $136M | — | — | 0.5 |
| Usana Health SciencesUSNA | $264M | — | 11.2 | 0.3 |
| AlicoALCO | $277M | 178.1 | — | 16.2 |
| Beyond MeatBYND | $119M | — | — | 0.5 |
| Peer median | 95.1 | 10.6 | 0.4 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: NAGE financials · NAGE returns
No forecast, no recommendation. This page describes Niagen Bioscience Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.